Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens
Open Access
- 1 January 2009
- journal article
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 6 (1) , 13
Abstract
Antiretrovirals used to treat HIV-infected patients have the potential to adversely affect serum lipid profiles and increase the risk of cardiovascular disease which is an emerging concern among HIV-infected patients. Since boosted atazanavir and efavirenz are both considered preferred antiretrovirals a head to head comparison of their effects on serum lipids is needed.Keywords
This publication has 12 references indexed in Scilit:
- Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Class of Antiretroviral Drugs and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2007
- Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV-infected IndividualsClinical Pharmacology & Therapeutics, 2007
- Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemiaAIDS, 2007
- Comparisons of Causes of Death and Mortality Rates Among HIV-Infected PersonsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Associations among Race/Ethnicity, ApoC-III Genotypes, and Lipids in HIV-1-Infected Individuals on Antiretroviral TherapyPLOS Medicine, 2006
- Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?The Journal of Infectious Diseases, 2004
- The Women's Interagency HIV Study. WIHS Collaborative Study Group.1998
- THE MULTICENTER AIDS COHORT STUDY: RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTSAmerican Journal of Epidemiology, 1987